UK markets closed

Aegon N.V. (AEGOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.41250.0000 (0.00%)
At close: 10:31AM EDT
Full screen
Loading interactive chart…
  • Reuters

    European shares tick higher; Aegon shines on forecast raise

    European shares edged higher on Thursday after a strong rally in the previous session on signs of U.S. inflation cooling, while Aegon climbed after the Dutch insurer raised its full-year forecast. The pan-European STOXX 600 index rose 0.1%, after clocking its best session in nearly two weeks on Wednesday on bets that a softer-than-expected U.S. inflation reading would encourage the Federal Reserve to become less aggressive on interest rates hikes. "Even if European stocks are not rallying as some of their counterparts today, they're going up as the interpretation by markets is that the inflation numbers were synonymous with the Fed changing its policy," said Sebastian Paris-Horvitz, head of research at La Banque Postale Asset Management.

  • Reuters

    Aegon raises capital, cash flow forecasts in boost to shares

    (Reuters) -Insurer Aegon raised its forecasts for full-year operating capital generation and 2021-2023 free cash flow on Thursday after a quarterly earnings beat, lifting its shares more than 8%. The Dutch group, which has significant operations in the United States, forecast full-year operating capital generation of around 1.4 billion euros ($1.44 billion), from about 1.2 billion previously. It said cumulative free cash flow over the period 2021 to 2023 was expected to be at least 2.2 billion euros, well above its previous target of 1.4 to 1.6 billion.

  • Globe Newswire

    Aegon reports second quarter 2022 results

    Please click here to access all 2Q 2022 results related documents. The Hague, August 11, 2022 - Steady progress on transformation allows Aegon to increase its free cash flow outlook Net loss of EUR 348 million due to one-time charges and a non-economic loss on interest rate hedges in the USOperating result of EUR 538 million; a decrease of 11% on a constant currency basis compared with the second quarter of 2021. Benefits from expense savings, growth initiatives and favorable claims experience a